Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health minister

Wed, 09th Sep 2020 07:15

LONDON, Sept 9 (Reuters) - Britain's Health Secretary Matt
Hancock said on Wednesday that AstraZeneca's decision to pause
its coronavirus vaccine trials was a challenge but would not
necessarily set back efforts to develop a vaccine.

AstraZeneca Plc said it had paused global trials,
including large late-stage trials, of its experimental
coronavirus vaccine due to an unexplained illness in a study
participant.

"It is obviously a challenge to this particular vaccine
trial," Hancock said on Sky News when asked about the pause in
the trial. "It's not actually the first time this has happened
to the Oxford vaccine."

Asked whether it would set back the vaccine development
process, he said: "Not necessarily, it depends on what they find
when they do the investigation."
(Reporting by Guy Faulconbridge and Estelle Shirbon; editing by
Michael Holden)

Related Shares

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the w...

27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation readin...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.